CPRX Q1 2021 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30M+3.7% YoY

Gross Profit

$26M84.5% margin

Operating Income

$10M32.4% margin

Net Income

$8M25.4% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

-2.6%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$197M

Total Liabilities

$19M

Stockholders' Equity

$179M

Cash & Equivalents

$127M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$29M	+3.7%
Gross Profit	$26M	$25M	+2.2%
Operating Income	$10M	$11M	-8.4%
Net Income	$8M	$10M	-26.5%